Home > Healthcare > Pharmaceuticals > Finished Drug Form > Aesthetic Injectables Market
Aesthetic Injectables Market was valued at USD 13.2 billion in 2023 and is anticipated to showcase a growth of 10.2% to reach USD 31.3 billion by 2032. Aesthetic injectables refer to non-surgical cosmetic procedures that involve injecting substances into the skin to enhance or alter its appearance. These procedures are often performed for aesthetic purposes to address concerns such as wrinkles, fine lines, volume loss, and facial contouring among others.
The growth of the aesthetic injectables market is propelled by several factors, including the increasing aging population seeking non-surgical solutions for signs of aging, rising beauty consciousness across age groups, ongoing technological advancements for improving product safety and efficacy, and the minimally invasive nature of these procedures. According to International Society of Aesthetic Plastic Surgery, around 7.3 million non-surgical botulinum toxin procedures were performed. Thus, the growing awareness of aesthetic procedures and the availability of non-surgical options have contributed to an expanding patient base seeking injectable treatments.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Aesthetic Injectables Market Size in 2023: | USD 13.2 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 10.2% |
2024 – 2032 Value Projection: | USD 31.3 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 240 |
Tables, Charts & Figures: | 430 |
Segments covered: | Type, Gender, Age Group, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|